Form 8-K - Current report:
SEC Accession No. 0001654954-25-008035
Filing Date
2025-07-14
Accepted
2025-07-14 16:59:10
Documents
16
Period of Report
2025-07-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K zivo_8k.htm   iXBRL 8-K 31268
2 COMMON STOCK PURCHASE WARRANT zivo_ex41.htm EX-4.1 85379
3 BRIDGE PROMISSORY NOTE zivo_ex101.htm EX-10.1 66796
  Complete submission text file 0001654954-25-008035.txt   351183

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA zivo-20250708.xsd EX-101.SCH 6305
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE zivo-20250708_lab.xml EX-101.LAB 15813
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE zivo-20250708_cal.xml EX-101.CAL 898
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zivo-20250708_pre.xml EX-101.PRE 11585
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zivo-20250708_def.xml EX-101.DEF 5365
18 EXTRACTED XBRL INSTANCE DOCUMENT zivo_8k_htm.xml XML 5379
Mailing Address 21 E. LONG LAKE ROAD SUITE 100 BLOOMFIELD HILLS MI 48304
Business Address 21 E. LONG LAKE ROAD SUITE 100 BLOOMFIELD HILLS MI 48304 (248) 452 9866
Zivo Bioscience, Inc. (Filer) CIK: 0001101026 (see all company filings)

EIN.: 870699977 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40449 | Film No.: 251122302
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)